Our subsidiaries

Panpharma France

  • A presence dating back 30 years
  • Our range: 40 specialities, most notably focussing on antibiotics, anaesthetics and cardio-vascular system specialities (see the product catalogue France)
  • Market leader in France in injectable antibiotic therapy with a wide and varied range of 22 antibiotics belonging to 15 families
  • Approved status in 95% of state hospitals and 100% of purchasing centres serving private clinics. Accordingly, we have been approved by Assistance publique – Hôpitaux de Paris (AP-HP), by Assistance publique – Hôpitaux de Marseille (AP-HM), by Hospices civils de Lyon (HCL), by all the CHU (university teaching hospitals), by regional, military and local hospitals, by hospital centres specialising in psychiatry, by Unicancer centres, by most dialysis centres and by EPRUS, the health emergency preparation and response institution
  • A competent and available marketing team

Since 1998

40 specialities

95% of state hospitals

Panpharma Germany

  • A presence dating back more than 25 years via our subsidiary, Rotexmedica
  • Our range: 30 injectable specialities, most notably focussing on hormones, corticosteroids and anaesthetics (see the product catalogue Germany)
  • Daily supply of Rotexmedica heparin sodium to the majority of dialysis centres
  • Approved status with all hospital procurement centres (SANA, PBMG, GENUA, EKKEG Städtetag and AGKAMED), with the largest teaching hospitals (including Charité Berlin, UKE Hamburg and UNI-Klinikum Frankfurt) and with the majority of private hospital centres (including Klinikum Nürnberg and Asklepios).

Since 1981

30 specialities

95% of state hospitals

Panpharma United Kingdom

  • Subsidiary founded in 2015
  • Our range: 11 drugs (ceftriaxone, dexamethasone, droperidol, erythromycin, heparin sodium, hydrocortisone, ketamine, linezolid, oxytocin, thiopental and voriconazole) which will be supplemented each year by other Group products (see our product information)

Since 2015

11 drugs

Panpharma Nordics

  • Subsidiary founded in 2017, established in Norway and covering Denmark, Norway, Sweden and Finland
  • Our range: 3 drugs (erythromycin, midazolam and penicillin G sodium) which will be supplemented each year by other Group products

Since 2017

3 drugs